Aspen Pharmacare Holdings Limited
APN.JO

$
Marketcap
$0.00
Share price
Country
$-60.00
Change (1 day)
$25296.00
Year High
$16096.00
Year Low

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.

marketcap

P/E ratio for Aspen Pharmacare Holdings Limited (APN.JO)

P/E ratio as of 2023: 23.04

According to Aspen Pharmacare Holdings Limited's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 23.04. At the end of 2022 the company had a P/E ratio of 15.60.

P/E ratio history for Aspen Pharmacare Holdings Limited from 2002 to 2023

PE ratio at the end of each year

Year P/E ratio
2023 23.04
2022 15.60
2021 9.71
2020 15.40
2019 14.05
2018 7.39
2017 19.61
2016 25.69
2015 38.45
2014 31.58
2013 27.22
2012 29.04
2011 19.49
2010 14.05
2009 15.46
2008 14.47
2007 12.72
2006 17.68
2005 19.41
2004 16.13
2003 12.50
2002 9.84